Jason Johnson
Overview
Jason Johnson is a partner in Crowell’s Health Care and Privacy & Cybersecurity Groups, where he draws on his experience as a former research scientist to advise clients on complex compliance, legal, regulatory, and transactional matters. He helps clients in the health care and life sciences industries navigate data privacy and cybersecurity issues under U.S. and European law. He also offers strategic insights to assist clients with product development, marketing, clinical research, and other core business initiatives.
Career & Education
- University of North Carolina at Chapel Hill, B.S.
- Franklin Pierce Law Center, J.D., magna cum laude
- New York
- U.S. District Court for the Eastern District of New York
- U.S. District Court for the Southern District of New York
- U.S. Patent and Trademark Office (USPTO)
- American Health Lawyers Association
- New York State Bar Association
- American Bar Association
Jason's Insights
Client Alert | 2 min read | 04.24.24
FTC Continues Focus on Tracking Technologies and Personal Health Data
The Federal Trade Commission (FTC) recently entered into a settlement with Monument, Inc., an alcohol addiction treatment service, for allegedly disclosing users’ personal health data to third-party advertising platforms without consumer consent and violating their own website claims to consumers with respect to the disclosure of such data. The action follows other settlements by the FTC focused on tracking technologies collecting sensitive health information through web pages and web portals. “This action continues the FTC’s work to ensure strict limits on how firms handle sensitive health data, rather than putting the onus on consumers to protect themselves,” said Samuel Levine, Director of the FTC’s Bureau of Consumer Protection. “Following on the heels of actions against GoodRx, BetterHelp, and Premom, the market should be getting the message that consumer health data should be handled with extreme caution.”
Speaking Engagement | 03.13.24
"Best Practices in Recruiting for Health Equity: Designing a Successful Protocol for Recruitment," Clinical Trials Masterclass, New York, NY
Event | 03.13.24 - 03.14.24
Speaking Engagement | 03.13.24
“Presentation of Attendee Clinical Trials With Focus on Recruiting,” Clinical Trials Masterclass, New York, NY
Jason's Insights
Client Alert | 2 min read | 04.24.24
FTC Continues Focus on Tracking Technologies and Personal Health Data
The Federal Trade Commission (FTC) recently entered into a settlement with Monument, Inc., an alcohol addiction treatment service, for allegedly disclosing users’ personal health data to third-party advertising platforms without consumer consent and violating their own website claims to consumers with respect to the disclosure of such data. The action follows other settlements by the FTC focused on tracking technologies collecting sensitive health information through web pages and web portals. “This action continues the FTC’s work to ensure strict limits on how firms handle sensitive health data, rather than putting the onus on consumers to protect themselves,” said Samuel Levine, Director of the FTC’s Bureau of Consumer Protection. “Following on the heels of actions against GoodRx, BetterHelp, and Premom, the market should be getting the message that consumer health data should be handled with extreme caution.”
Speaking Engagement | 03.13.24
"Best Practices in Recruiting for Health Equity: Designing a Successful Protocol for Recruitment," Clinical Trials Masterclass, New York, NY
Event | 03.13.24 - 03.14.24
Speaking Engagement | 03.13.24
“Presentation of Attendee Clinical Trials With Focus on Recruiting,” Clinical Trials Masterclass, New York, NY